Showing results (391-400 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|December 27, 2022
Attention-deficit hyperactivity symptoms and risk of alcohol use relapseTakahiro Kawata, Genichi Sugihara, Yoichi Kakibuchi, et al.
Neuropsychopharmacology Reports|January 16, 2023
Post-therapy plasma concentrations of quetiapine in Taiwanese patientsCho-Yin Huang, Yen-Feng Lin, Chia-Ru Chen, et al.
Neuropsychopharmacology Reports|November 24, 2022
Preliminary analysis of hippocampus synaptic apoptosis and microglial phagocytosis induced by severe restraint stressShingo Enomoto, Masahiro Ohgidani, Noriaki Sagata, et al.
Neuropsychopharmacology Reports|June 28, 2021
Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label complianceDaniel Fife, Erica A Voss, Jill Hardin, et al.
Neuropsychopharmacology Reports|June 1, 2022
Baseline risk characterization of early versus later adopters of long-acting paliperidone palmitate formulationsDaniel Fife, Stephen Fortin, Hong Qiu, et al.
Neuropsychopharmacology Reports|June 18, 2022
Anodal transcranial direct current stimulation sustainably increases EEG alpha activity in patients with schizophreniaBenjamin Pross, Wolfgang Strube, Irina Papazova, et al.
Neuropsychopharmacology Reports|October 10, 2020
Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal cells from neurofibromatosis type 1 patientsNoriaki Sagata, Shin-Ichi Kano, Masahiro Ohgidani, et al.
Pageof 66